Related Experiment Videos
Experimental studies with perfluoro-octane for hemostasis during vitreoretinal surgery
C A Moreira Júnior1, C E Uscocovich, A T Moreira
1Department of Ophthalmology, Universidade Federal do Parana, Curitiba, Brazil.
Retina (Philadelphia, Pa.)
|January 1, 1997
Summary
Perfluoro-octane effectively reduced bleeding during vitreoretinal surgery in rabbits. This study found no significant impact on blood coagulation, suggesting a localized effect for hemostasis.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Biomaterials
Background:
- Intraoperative bleeding is a significant challenge in vitreoretinal surgery.
- Effective hemostasis is crucial for successful surgical outcomes.
- Perfluoro-octane is a dense, inert liquid with potential applications in ophthalmology.
Purpose of the Study:
- To evaluate the efficacy of perfluoro-octane in controlling intraoperative bleeding during vitreoretinal surgery.
- To assess the impact of perfluoro-octane on coagulation parameters.
- To investigate perfluoro-octane's role in achieving hemostasis in an animal model.
Main Methods:
- An in vitro study analyzed coagulation profiles of blood with and without perfluoro-octane.
- An in vivo rabbit model simulated retinal arterial bleeding in vitrectomized and aphakic eyes.
- Perfluoro-octane was administered intraocularly to assess its effect on hemostasis time.
Main Results:
- In vitro tests showed perfluoro-octane did not significantly alter blood coagulation profiles.
- In vivo, intraocular perfluoro-octane markedly decreased the time to achieve hemostasis.
- These results were consistent across various infusion bottle heights in the rabbit model.
Conclusions:
- Perfluoro-octane demonstrates potential as an agent for managing intraoperative bleeding in vitreoretinal procedures.
- The hemostatic effect appears localized and not directly mediated by the clotting cascade.
- Further investigation may support the clinical application of perfluoro-octane for surgical hemostasis.